EUVIMEDEUVIMED entdecken
Crossref

Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies

Aleksandra Gostyńska, Katarzyna Dettlaff, Anna Jelińska, Maciej Stawny

Journal of Pharmaceutical Sciences · 2023

DOI: 10.1016/j.xphs.2023.08.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2023. Verfasst von Aleksandra Gostyńska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Poznań, Poland. Electronic address: ag…. Hauptthemen laut MEDLINE: Aminoglycosides, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Narodowym Centrum Nauki, Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Aminoglycosides (AMGs) are broad-spectrum bactericidal antibiotics that can resolve bacterial infections co-existing with COVID-19 or exploit their potential antiviral activities. Patients presenting the most severe forms of COVID-19 due to escalating catabolism and significant lean body mass loss often require the concomitant administration of parenteral nutrition (PN) and antibiotics. The Y-site administration is one of the approaches allowing the co-administration of two intravenous medications in patients with limited vascular access. Our study aimed to investigate the compatibility of AMGs and selected commercial PN admixtures enriched in omega-3 fatty acids. METHODS: Gentamycin (GM), amikacin (AM), and tobramycin (TM) solutions for infusion were combined with Nutriflex Omega Special (NOS) and Smofkabiven (SFK). Three different volume ratios were investigated: 1:2, 1:1, and 2:1, simulating Y-site administration. Samples underwent visual examination and determination of the lipid emulsion particle size, zeta potential, and pH immediately after preparation and after four hours of storage at room temperature (22 ± 2 °C) with sunlight exposure. RESULTS: GM and AM combined with NOS in all studied ratios met the set-up acceptance criteria. The addition of TM to NOS in a 2:1 volume ratio and all tested AMGs to SFK in all studied combinations significantly influenced the stability of the oil-water system leading to the appearance of globules larger than 5 µm exceeding the pharmacopeial limit of 0.05% immediately after preparation or after four hours of storage. CONCLUSION: In conclusion, our study showed that NOS was less prone to destabilization of oil-in-water systems by AMGs than SFK. In justified clinical cases, due to the lack of appearance of precipitate or enlarged lipid droplets, the combined administration of GM and AM with the NOS could be considered, provided tested volume ratios of the drug and MCB in the infusion line are maintained. However, it should be noted that such an infusion may be associated with the risk of changes in the pharmacokinetics of the drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminoglycosidesCOVID-19HumansAnti-Bacterial AgentsGentamicinsTobramycinParenteral NutritionWater

Stichwörter der Autor:innen

AminoglycosidesCOVID-19Nutriflex omega specialSmofkabivenY-site administrationcompatibility tests

Substanzen

AminoglycosidesAnti-Bacterial AgentsGentamicinsTobramycinWater

Autor:innen und Institutionen

  • Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Poznań, Poland. Electronic address: agostynska@ump.edu.pl.
  • Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Poznań, Poland.

Förderung

  • Narodowym Centrum Nauki
  • Narodowe Centrum Nauki

Zitieren

APA

Gostyńska, A., Dettlaff, K., Jelińska, A., & Stawny, M. (2023). Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2023.08.007

Vancouver

Gostyńska A, Dettlaff K, Jelińska A, Stawny M. Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies. Journal of Pharmaceutical Sciences. 2023. doi:10.1016/j.xphs.2023.08.007

BibTeX
@article{Gostyska2023,
  author = {Gostyńska, Aleksandra and Dettlaff, Katarzyna and Jelińska, Anna and Stawny, Maciej},
  title = {Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2023},
  doi = {10.1016/j.xphs.2023.08.007}
}
Kostenlos starten →